Status:
COMPLETED
Heterotopic Ossification Prophylaxis
Lead Sponsor:
University of Maryland, Baltimore
Conditions:
Acetabular Fracture
Heterotopic Ossification
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
One complication that can occur after surgery on the acetabulum is the development of bone in abnormal places such as muscle and soft tissues. There is some evidence that a single dose of radiation to...
Detailed Description
Heterotopic ossification (HO) is a common complication after surgical fixation of acetabular fractures, with incidence rates reported as high as 90%. HO can be a debilitating complication and surgical...
Eligibility Criteria
Inclusion
- Adult aged 18+ with an acute acetabular fracture
- Indicated for surgical fixation via a posterior or combined anterior and posterior approach
Exclusion
- Contraindication to radiotherapy such as history of cancer/RT
- Patients that are getting an acute total hip arthroplasty at the time of fixation of the acetabular fracture
- Not English speaking
- Not a Maryland resident or likely to have difficulty returning for post-op follow up(s) (i.e. homeless, incarceration)
Key Trial Info
Start Date :
May 9 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
117 Patients enrolled
Trial Details
Trial ID
NCT04867278
Start Date
May 9 2021
End Date
December 31 2023
Last Update
December 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Maryland, Shock Trauma Center
Baltimore, Maryland, United States, 21201